# Safety of an Inactivated Enterovirus Type 71 Vaccine in Healthy Adults

> **NCT01273233** · PHASE1 · COMPLETED · sponsor: **Sinovac Biotech Co., Ltd** · enrollment: 36 (actual)

## Conditions studied

- Infection; Viral, Enterovirus

## Interventions

- **BIOLOGICAL:** Inactivated Enterovirus Type 71 Vaccine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01273233
- **Lead sponsor:** Sinovac Biotech Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2013-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01273233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01273233, "Safety of an Inactivated Enterovirus Type 71 Vaccine in Healthy Adults". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01273233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*